Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Robert Fuhlbrigge

Concepts (504)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Skin
23
2025
745
2.580
 Why?
Arthritis, Juvenile
9
2022
56
1.760
 Why?
Vaccinia virus
7
2017
43
1.340
 Why?
E-Selectin
15
2019
57
1.170
 Why?
Rheumatic Diseases
3
2021
80
1.160
 Why?
Vaccinia
4
2017
21
0.990
 Why?
CD8-Positive T-Lymphocytes
8
2025
913
0.890
 Why?
Membrane Glycoproteins
13
2007
500
0.800
 Why?
Cell Adhesion
14
2015
467
0.770
 Why?
Blotting, Western
7
2015
1225
0.750
 Why?
Immunologic Surveillance
4
2011
25
0.730
 Why?
Rheumatology
1
2021
120
0.650
 Why?
T-Lymphocytes
13
2019
1998
0.650
 Why?
Immunologic Memory
8
2025
369
0.630
 Why?
Selectins
5
2015
8
0.630
 Why?
Pulmonary Alveoli
1
2021
405
0.590
 Why?
Immune System
3
2011
177
0.580
 Why?
Skin Diseases
3
2009
148
0.580
 Why?
Down Syndrome
2
2021
490
0.570
 Why?
Scleroderma, Localized
4
2024
10
0.570
 Why?
Hemorrhage
2
2023
723
0.550
 Why?
Skin Diseases, Infectious
1
2017
15
0.550
 Why?
T-Lymphocytes, Regulatory
6
2020
387
0.530
 Why?
Interleukin 1 Receptor Antagonist Protein
2
2017
253
0.520
 Why?
Receptors, Lymphocyte Homing
5
2007
16
0.510
 Why?
Cell Adhesion Molecules
3
2007
181
0.500
 Why?
Antirheumatic Agents
4
2022
290
0.500
 Why?
Cell Movement
16
2017
969
0.460
 Why?
Leukocytes
6
2006
312
0.450
 Why?
Lung Diseases
1
2021
768
0.450
 Why?
Interleukin-1alpha
2
2020
58
0.450
 Why?
Intercellular Adhesion Molecule-1
4
2019
139
0.450
 Why?
Mechanical Phenomena
1
2015
84
0.440
 Why?
Programmed Cell Death 1 Receptor
3
2025
250
0.410
 Why?
Dendritic Cells
8
2016
484
0.400
 Why?
P-Selectin
10
2012
28
0.390
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2012
87
0.370
 Why?
Scleroderma, Systemic
3
2024
122
0.370
 Why?
Lymphoma, T-Cell, Cutaneous
5
2012
43
0.370
 Why?
Antibodies, Monoclonal
12
2020
1428
0.370
 Why?
Animals
48
2025
36768
0.360
 Why?
Models, Immunological
4
2012
100
0.350
 Why?
Leukosialin
3
2011
14
0.340
 Why?
T-Lymphocyte Subsets
5
2017
425
0.340
 Why?
Child
29
2024
21968
0.330
 Why?
L-Selectin
7
2000
26
0.330
 Why?
Systemic Vasculitis
1
2009
2
0.330
 Why?
Mice, Knockout
12
2025
2999
0.320
 Why?
Mice
32
2025
17731
0.300
 Why?
Humans
76
2025
136783
0.290
 Why?
T-Lymphocytes, Cytotoxic
2
2015
172
0.290
 Why?
Cricetinae
8
2015
288
0.280
 Why?
Blood Vessels
1
2009
187
0.280
 Why?
Skin Neoplasms
4
2012
852
0.280
 Why?
Mice, Inbred C57BL
16
2025
5744
0.280
 Why?
Th17 Cells
2
2020
109
0.280
 Why?
Antibodies, Viral
1
2012
622
0.280
 Why?
Comparative Effectiveness Research
2
2019
150
0.280
 Why?
Antigens, Neoplasm
9
2007
320
0.270
 Why?
CHO Cells
6
2015
160
0.270
 Why?
Melanoma
3
2012
757
0.270
 Why?
Tumor Necrosis Factor-alpha
2
2012
1242
0.270
 Why?
Immunity, Innate
5
2012
826
0.270
 Why?
Chemokines, CC
3
2004
33
0.260
 Why?
Interleukin-1
7
1989
963
0.260
 Why?
Lymphocytes, Tumor-Infiltrating
2
2012
209
0.250
 Why?
Lymphocyte Activation
5
2010
1150
0.240
 Why?
Monocytes
3
2005
561
0.240
 Why?
Biological Assay
1
2006
123
0.240
 Why?
Chemotaxis, Leukocyte
4
2013
138
0.230
 Why?
Lupus Vasculitis, Central Nervous System
1
2024
14
0.230
 Why?
Synovial Membrane
2
2024
117
0.220
 Why?
Neurofilament Proteins
1
2024
52
0.220
 Why?
Glial Fibrillary Acidic Protein
1
2024
99
0.220
 Why?
Microscopic Polyangiitis
1
2023
12
0.210
 Why?
Arthritis, Rheumatoid
2
2024
1164
0.210
 Why?
Methotrexate
4
2019
260
0.210
 Why?
Antigens, Differentiation, T-Lymphocyte
8
2007
98
0.210
 Why?
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
1
2023
23
0.210
 Why?
Churg-Strauss Syndrome
1
2023
26
0.210
 Why?
Granulomatosis with Polyangiitis
1
2023
44
0.210
 Why?
Glucocorticoids
3
2019
596
0.210
 Why?
Myositis
1
2023
52
0.200
 Why?
Thymus Gland
1
2004
313
0.200
 Why?
Granuloma
1
2023
91
0.200
 Why?
Transforming Growth Factor beta
1
2025
480
0.200
 Why?
Spondylarthropathies
1
2022
6
0.190
 Why?
Cricetulus
3
2015
109
0.190
 Why?
Keratinocytes
3
2016
248
0.190
 Why?
Gene Expression Regulation
4
2015
2603
0.180
 Why?
Adaptive Immunity
2
2020
164
0.180
 Why?
Adolescent
16
2024
21463
0.180
 Why?
Spondylitis, Ankylosing
1
2022
46
0.180
 Why?
Consensus
4
2024
679
0.180
 Why?
Spondylarthritis
1
2022
50
0.180
 Why?
Biomarkers
4
2024
4158
0.180
 Why?
Sarcoidosis
1
2023
159
0.180
 Why?
Melanoma, Experimental
2
2019
113
0.170
 Why?
Lupus Erythematosus, Systemic
1
2023
257
0.170
 Why?
Endothelium, Vascular
5
2019
925
0.170
 Why?
Immunization
2
2016
410
0.170
 Why?
CD4-Positive T-Lymphocytes
5
2016
1092
0.170
 Why?
Severity of Illness Index
3
2024
2831
0.170
 Why?
Immunomodulation
1
2020
97
0.160
 Why?
Female
31
2025
72840
0.160
 Why?
Neoplasm Proteins
3
2017
432
0.160
 Why?
Cellular Reprogramming
1
2020
98
0.160
 Why?
Advisory Committees
1
2020
219
0.150
 Why?
Keratin-14
2
2009
15
0.150
 Why?
Health Services Needs and Demand
1
2020
268
0.150
 Why?
Child, Preschool
12
2021
11069
0.150
 Why?
Mucocutaneous Lymph Node Syndrome
3
2012
93
0.150
 Why?
Cognitive Dysfunction
1
2023
385
0.150
 Why?
Cells, Cultured
14
2017
4194
0.140
 Why?
Interleukin-1beta
1
2020
372
0.140
 Why?
Immunoglobulin G
2
2012
886
0.140
 Why?
Ligands
10
2016
664
0.140
 Why?
Candida albicans
1
2017
53
0.140
 Why?
Candidiasis
1
2017
55
0.140
 Why?
Cell Polarity
2
2016
141
0.140
 Why?
Kaposi Varicelliform Eruption
1
2017
21
0.140
 Why?
Lymphadenitis
1
2016
6
0.130
 Why?
Hereditary Autoinflammatory Diseases
1
2016
7
0.130
 Why?
Administration, Cutaneous
1
2017
128
0.130
 Why?
Stomatitis, Aphthous
1
2016
10
0.130
 Why?
Pharyngitis
1
2016
26
0.130
 Why?
Interleukin-23
1
2016
19
0.130
 Why?
Clinical Protocols
1
2018
268
0.130
 Why?
Dermatomyositis
2
2009
27
0.130
 Why?
Receptors, CCR4
3
2012
22
0.130
 Why?
Fatty Acids, Nonesterified
1
2017
159
0.130
 Why?
Psoriasis
3
2017
102
0.120
 Why?
Virus Replication
2
2017
479
0.120
 Why?
Young Adult
6
2024
13126
0.120
 Why?
Interleukins
2
2016
251
0.120
 Why?
Immune Tolerance
2
2009
362
0.120
 Why?
Male
22
2024
67361
0.120
 Why?
Transcriptome
1
2021
971
0.120
 Why?
Interleukin-7 Receptor alpha Subunit
1
2015
12
0.120
 Why?
Neutrophils
4
2012
1234
0.120
 Why?
Mice, SCID
4
2020
367
0.120
 Why?
Cell Line
7
2011
2836
0.120
 Why?
Interleukin-2 Receptor alpha Subunit
1
2015
81
0.110
 Why?
Granzymes
1
2015
49
0.110
 Why?
Dermatitis, Atopic
2
2009
328
0.110
 Why?
Neoplasms
3
2020
2644
0.110
 Why?
Toll-Like Receptor 4
1
2016
273
0.110
 Why?
Receptors, Antigen, T-Cell
2
2010
721
0.110
 Why?
Interleukin-17
2
2017
120
0.110
 Why?
Hyaluronan Receptors
3
2011
103
0.110
 Why?
HLA-DR Antigens
1
2015
228
0.110
 Why?
Multiple Sclerosis, Relapsing-Remitting
1
2015
76
0.110
 Why?
Hematopoietic Stem Cells
2
2011
400
0.110
 Why?
Dermatitis, Allergic Contact
2
2011
73
0.110
 Why?
Receptors, CCR7
1
2013
32
0.110
 Why?
Lipid Metabolism
1
2017
512
0.100
 Why?
Microscopy
1
2015
144
0.100
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2012
20
0.100
 Why?
B-Lymphocytes
4
2011
846
0.100
 Why?
Interleukin-9
1
2012
9
0.100
 Why?
Biomechanical Phenomena
2
2015
808
0.100
 Why?
CD18 Antigens
1
2012
26
0.100
 Why?
Antigens, Ly
1
2012
44
0.100
 Why?
Neutrophil Infiltration
1
2012
107
0.090
 Why?
Lymphocyte Count
1
2012
150
0.090
 Why?
Interferon-gamma
2
2012
790
0.090
 Why?
Transforming Growth Factors
1
2011
3
0.090
 Why?
Neoplasm Transplantation
3
2019
256
0.090
 Why?
Randomized Controlled Trials as Topic
3
2018
1455
0.090
 Why?
Atherosclerosis
1
2016
415
0.090
 Why?
Langerhans Cells
1
2011
12
0.090
 Why?
Autoimmune Diseases
2
2007
459
0.090
 Why?
Antigens, CD34
1
2011
88
0.090
 Why?
Vaccination
2
2017
1378
0.090
 Why?
Inflammation
6
2012
2834
0.090
 Why?
Epidermis
2
2016
157
0.090
 Why?
Interleukin-6
1
2015
778
0.080
 Why?
Antigens, CD
2
2007
522
0.080
 Why?
Program Development
1
2012
365
0.080
 Why?
Integrins
1
2010
95
0.080
 Why?
Viral Load
1
2012
460
0.080
 Why?
Fucosyltransferases
3
2018
33
0.080
 Why?
Mice, Inbred BALB C
4
2018
1267
0.080
 Why?
Flow Cytometry
6
2013
1181
0.080
 Why?
Prospective Studies
4
2024
7583
0.080
 Why?
Metalloendopeptidases
4
2012
62
0.080
 Why?
Hypersensitivity, Delayed
2
2007
28
0.080
 Why?
Receptors, Interleukin-1
2
2006
216
0.080
 Why?
Microtubule-Associated Proteins
1
2010
195
0.080
 Why?
Lymph Nodes
4
2016
492
0.080
 Why?
Cytokines
3
2007
2088
0.080
 Why?
beta Catenin
1
2011
251
0.080
 Why?
Ovalbumin
1
2009
183
0.080
 Why?
Shear Strength
1
2009
67
0.080
 Why?
Mice, Transgenic
3
2009
2162
0.070
 Why?
Arthritis
2
2024
95
0.070
 Why?
Toll-Like Receptors
1
2009
185
0.070
 Why?
Joints
2
2024
105
0.070
 Why?
Rheology
1
2009
91
0.070
 Why?
Cell Differentiation
4
2025
1980
0.070
 Why?
Feasibility Studies
2
2024
947
0.070
 Why?
Cancer Vaccines
2
2012
173
0.070
 Why?
Protein Precursors
1
1988
132
0.070
 Why?
Self Tolerance
1
2007
28
0.070
 Why?
Cell Line, Tumor
4
2020
3399
0.070
 Why?
Vitamin A
1
2007
58
0.070
 Why?
MART-1 Antigen
1
2007
12
0.070
 Why?
Toll-Like Receptor 7
1
2007
39
0.070
 Why?
Cholecalciferol
1
2007
60
0.070
 Why?
Chemokine CCL17
2
2004
6
0.070
 Why?
CD8 Antigens
1
2007
75
0.070
 Why?
Drug Therapy, Combination
3
2019
1059
0.070
 Why?
Microcirculation
2
2005
145
0.070
 Why?
Receptors, Chemokine
2
2006
47
0.070
 Why?
Killer Cells, Natural
2
2007
445
0.070
 Why?
Apoptosis Regulatory Proteins
1
2007
188
0.060
 Why?
HeLa Cells
1
2008
636
0.060
 Why?
Polysaccharides
3
2011
84
0.060
 Why?
Th1 Cells
1
2007
143
0.060
 Why?
Case-Control Studies
3
2024
3537
0.060
 Why?
Up-Regulation
2
2009
843
0.060
 Why?
Vascular Cell Adhesion Molecule-1
3
2010
39
0.060
 Why?
Sialoglycoproteins
1
2006
159
0.060
 Why?
Methylprednisolone
2
2019
85
0.060
 Why?
Microscopy, Video
1
2006
25
0.060
 Why?
Urticaria
1
2006
38
0.060
 Why?
Neuraminidase
4
2001
25
0.060
 Why?
Transfection
1
1988
945
0.060
 Why?
Cell Lineage
1
2008
347
0.060
 Why?
Wiskott-Aldrich Syndrome Protein
1
2005
4
0.060
 Why?
Vitamin D
1
2009
395
0.060
 Why?
Viral Vaccines
1
2006
98
0.060
 Why?
Bone Marrow Cells
3
2002
316
0.060
 Why?
Polymerase Chain Reaction
1
2008
1059
0.060
 Why?
Graft vs Host Disease
1
2007
249
0.060
 Why?
Signal Transduction
5
2025
5065
0.060
 Why?
Immunologic Factors
1
2007
237
0.060
 Why?
Carrier Proteins
2
2006
768
0.060
 Why?
Disease Progression
3
2024
2750
0.060
 Why?
Membrane Proteins
3
1998
1162
0.060
 Why?
Neutrophil Activation
2
2012
80
0.060
 Why?
Practice Guidelines as Topic
1
2012
1568
0.060
 Why?
Adult
8
2024
37616
0.060
 Why?
Smallpox Vaccine
1
2004
23
0.050
 Why?
Monitoring, Immunologic
1
2004
23
0.050
 Why?
Th2 Cells
1
2005
176
0.050
 Why?
Immunosuppressive Agents
1
2009
890
0.050
 Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2004
52
0.050
 Why?
Leukocytosis
1
2003
31
0.050
 Why?
Purpura, Thrombocytopenic, Idiopathic
1
2003
15
0.050
 Why?
Cell Separation
3
2013
318
0.050
 Why?
Neoplastic Stem Cells
1
2008
397
0.050
 Why?
Antibodies, Antineutrophil Cytoplasmic
1
2023
36
0.050
 Why?
Lipopolysaccharides
1
1987
885
0.050
 Why?
Raynaud Disease
1
2003
5
0.050
 Why?
Coronary Vessels
1
2005
245
0.050
 Why?
Fasciitis
1
2023
12
0.050
 Why?
Neuroglia
1
2024
172
0.050
 Why?
Observer Variation
1
2024
345
0.050
 Why?
Mice, Inbred NOD
2
2019
601
0.050
 Why?
Immunocompetence
2
2017
42
0.050
 Why?
Neutropenia
1
2003
146
0.050
 Why?
Peripheral Nervous System Diseases
1
2003
128
0.050
 Why?
Microscopy, Fluorescence
1
2004
397
0.050
 Why?
Prednisone
2
2019
243
0.050
 Why?
DNA
2
1988
1458
0.050
 Why?
Chemokines, CXC
2
2005
70
0.050
 Why?
Recombinant Fusion Proteins
3
2012
663
0.050
 Why?
Syndrome
2
2016
357
0.050
 Why?
Image Processing, Computer-Assisted
1
2006
752
0.040
 Why?
Hemorheology
2
1999
22
0.040
 Why?
Registries
2
2020
2015
0.040
 Why?
B-Lymphocyte Subsets
1
2001
75
0.040
 Why?
Acute Disease
2
2020
1006
0.040
 Why?
Models, Biological
1
2008
1769
0.040
 Why?
Calcinosis
1
2002
235
0.040
 Why?
Immunoblotting
2
1998
307
0.040
 Why?
Disease Models, Animal
3
2020
4279
0.040
 Why?
Fibrosis
1
2023
551
0.040
 Why?
Glycosylation
2
2012
163
0.040
 Why?
Critical Pathways
1
2020
89
0.040
 Why?
Immunohistochemistry
1
2004
1731
0.040
 Why?
Macrophages
1
1987
1541
0.040
 Why?
Lower Extremity
1
2023
424
0.040
 Why?
Integrin beta Chains
1
2018
8
0.040
 Why?
Remission Induction
2
2010
287
0.040
 Why?
Immunophenotyping
2
2015
319
0.040
 Why?
Administration, Intravenous
1
2019
154
0.040
 Why?
Rare Diseases
1
2019
101
0.040
 Why?
Protein Binding
3
2012
2223
0.040
 Why?
Calcium
2
2012
1197
0.040
 Why?
Information Dissemination
1
2020
217
0.040
 Why?
Needs Assessment
1
2020
369
0.040
 Why?
Endothelium, Lymphatic
1
1998
12
0.040
 Why?
Infant, Newborn
2
2021
6046
0.040
 Why?
Epitopes
2
1998
480
0.040
 Why?
Interprofessional Relations
1
2020
280
0.040
 Why?
Allografts
1
2018
146
0.040
 Why?
Interleukin-2
2
2010
454
0.040
 Why?
Culture Media, Serum-Free
1
1997
48
0.040
 Why?
Antigen-Presenting Cells
2
1989
156
0.040
 Why?
Oligosaccharides
1
1998
61
0.030
 Why?
Middle Aged
4
2024
33200
0.030
 Why?
Down-Regulation
2
2012
657
0.030
 Why?
Pain
1
2023
755
0.030
 Why?
Familial Mediterranean Fever
1
2016
8
0.030
 Why?
Turkey
1
2016
22
0.030
 Why?
Altitude
1
2021
482
0.030
 Why?
N-Formylmethionine Leucyl-Phenylalanine
1
1996
54
0.030
 Why?
Administration, Oral
1
2019
808
0.030
 Why?
Edetic Acid
1
1996
50
0.030
 Why?
Boston
1
2016
91
0.030
 Why?
Fatty Acid-Binding Proteins
1
2017
70
0.030
 Why?
Hospitals
1
2021
677
0.030
 Why?
Endopeptidases
1
1996
90
0.030
 Why?
Epitopes, T-Lymphocyte
1
1997
187
0.030
 Why?
Antibodies
2
2012
412
0.030
 Why?
Synovial Fluid
1
2016
69
0.030
 Why?
Chelating Agents
1
1996
75
0.030
 Why?
Logistic Models
1
2021
2060
0.030
 Why?
Program Evaluation
1
2020
886
0.030
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2017
337
0.030
 Why?
Reproducibility of Results
1
2024
3272
0.030
 Why?
Biological Transport
1
2017
411
0.030
 Why?
Cell Membrane
3
1988
736
0.030
 Why?
Tumor Microenvironment
1
2020
671
0.030
 Why?
Lymphocytes
1
1998
395
0.030
 Why?
Chemokines
1
1996
228
0.030
 Why?
Infant
4
2012
9442
0.030
 Why?
Neurons
1
2024
1583
0.030
 Why?
Antibodies, Monoclonal, Murine-Derived
2
2007
88
0.030
 Why?
Hematopoiesis
1
2016
190
0.030
 Why?
Dermatitis, Contact
2
2007
17
0.030
 Why?
Eosinophils
1
1997
331
0.030
 Why?
Glycolipids
1
1995
42
0.030
 Why?
Protein Processing, Post-Translational
1
1997
467
0.030
 Why?
Molecular Sequence Data
3
2012
2903
0.030
 Why?
Antigens
1
2016
358
0.030
 Why?
Rituximab
2
2007
178
0.030
 Why?
Primary Cell Culture
1
2015
171
0.030
 Why?
Pilot Projects
1
2019
1697
0.030
 Why?
Cell Survival
1
2017
1117
0.030
 Why?
Treatment Outcome
4
2012
10764
0.030
 Why?
Contractile Proteins
1
2012
15
0.030
 Why?
Oxidation-Reduction
1
2017
1062
0.030
 Why?
Filamins
1
2012
28
0.020
 Why?
Radiation Chimera
1
2012
30
0.020
 Why?
Nuclear Receptor Subfamily 1, Group F, Member 3
1
2012
14
0.020
 Why?
Receptors, Leukotriene B4
1
2012
7
0.020
 Why?
Global Health
1
2016
386
0.020
 Why?
Carcinoma, Lewis Lung
1
2012
15
0.020
 Why?
Leukotriene B4
1
2012
42
0.020
 Why?
Receptors, Interleukin
1
2012
45
0.020
 Why?
Peritoneum
1
2012
43
0.020
 Why?
Mice, Inbred CBA
2
1989
54
0.020
 Why?
Mutant Proteins
1
2012
101
0.020
 Why?
Antineoplastic Agents
1
2003
2129
0.020
 Why?
Quality Improvement
1
2020
1152
0.020
 Why?
Local Lymph Node Assay
1
2011
1
0.020
 Why?
Microfilament Proteins
1
2012
131
0.020
 Why?
Lymphoid Tissue
2
2005
75
0.020
 Why?
Pandemics
1
2020
1619
0.020
 Why?
Chemotaxis
1
2012
130
0.020
 Why?
Fibroblasts
2
2005
989
0.020
 Why?
Chemokine CXCL12
2
2005
80
0.020
 Why?
Biomedical Research
1
2018
689
0.020
 Why?
Genetic Variation
1
2016
985
0.020
 Why?
Cloning, Molecular
1
2012
534
0.020
 Why?
Retrospective Studies
3
2021
15564
0.020
 Why?
Risk Assessment
1
2020
3429
0.020
 Why?
Natural Killer T-Cells
1
2011
67
0.020
 Why?
Tumor Burden
1
2012
309
0.020
 Why?
Mast Cells
1
2012
146
0.020
 Why?
Lymphatic Metastasis
1
2012
350
0.020
 Why?
Motor Activity
1
2016
719
0.020
 Why?
Longitudinal Studies
2
2009
2847
0.020
 Why?
Minor Histocompatibility Antigens
1
2010
48
0.020
 Why?
Colorado
1
2020
4491
0.020
 Why?
Blood Circulation
1
2010
41
0.020
 Why?
Congresses as Topic
1
2011
233
0.020
 Why?
Diphtheria Toxin
1
2010
65
0.020
 Why?
Diagnosis, Differential
2
2005
1483
0.020
 Why?
Risk Factors
2
2016
10331
0.020
 Why?
Mass Spectrometry
1
2012
739
0.020
 Why?
Complement System Proteins
1
2012
327
0.020
 Why?
Antibodies, Anti-Idiotypic
1
1989
59
0.020
 Why?
Binding Sites, Antibody
1
1988
42
0.020
 Why?
Antigen-Antibody Reactions
1
1988
55
0.020
 Why?
Incidence
1
2016
2788
0.020
 Why?
Precipitin Tests
1
1988
100
0.020
 Why?
RNA, Small Interfering
1
2011
621
0.020
 Why?
Follow-Up Studies
2
2009
5115
0.020
 Why?
Pregnancy
1
2021
6731
0.020
 Why?
Immunotherapy, Adoptive
1
2012
324
0.020
 Why?
Cell Proliferation
1
2016
2473
0.020
 Why?
Interferon-alpha
1
2010
198
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
2
2001
345
0.020
 Why?
Aged
2
2023
23729
0.020
 Why?
Muscle Weakness
1
2009
86
0.020
 Why?
Homeodomain Proteins
1
2012
504
0.020
 Why?
Immunoglobulins, Intravenous
1
2009
132
0.020
 Why?
Allergens
1
2011
407
0.020
 Why?
Amino Acid Sequence
1
2012
2145
0.020
 Why?
Tissue Array Analysis
1
2008
57
0.020
 Why?
Phenotype
1
2016
3199
0.020
 Why?
Stress, Mechanical
2
2001
480
0.020
 Why?
Immunoassay
1
1988
113
0.020
 Why?
Transplantation, Heterologous
1
2008
195
0.020
 Why?
Receptors, Immunologic
1
1989
217
0.020
 Why?
Peritoneal Cavity
1
1987
31
0.020
 Why?
Cell Compartmentation
1
1987
52
0.020
 Why?
Plasmids
1
1988
362
0.020
 Why?
Umbilical Veins
2
1997
61
0.020
 Why?
Receptors, CCR6
1
2006
4
0.020
 Why?
Receptors, Interleukin-2
1
2006
66
0.020
 Why?
Immunoglobulins
1
2007
171
0.020
 Why?
CD4 Antigens
1
2006
141
0.020
 Why?
Genetic Linkage
1
1987
298
0.020
 Why?
Infusions, Intravenous
1
2007
408
0.020
 Why?
Mice, Nude
1
2008
692
0.020
 Why?
Cell Division
1
2008
796
0.020
 Why?
Papilledema
1
2006
39
0.020
 Why?
Macrophage Activation
1
1987
201
0.020
 Why?
Vaccines, Attenuated
1
2006
131
0.020
 Why?
Neoplasm Staging
1
2010
1373
0.020
 Why?
Proteomics
1
2012
1108
0.020
 Why?
Antigens, Viral
1
2006
180
0.020
 Why?
Forkhead Transcription Factors
1
2006
190
0.020
 Why?
Dose-Response Relationship, Drug
2
2007
2045
0.010
 Why?
Dilatation, Pathologic
1
2005
61
0.010
 Why?
NLR Family, Pyrin Domain-Containing 3 Protein
1
2006
151
0.010
 Why?
Receptors, CXCR4
1
2005
85
0.010
 Why?
Meningitis
1
2006
79
0.010
 Why?
Recombinant Proteins
1
1988
1354
0.010
 Why?
Gene Expression Profiling
1
2012
1768
0.010
 Why?
Drug Administration Schedule
1
2007
783
0.010
 Why?
Cross-Sectional Studies
1
2016
5417
0.010
 Why?
Fibronectins
1
2005
133
0.010
 Why?
Cytoskeletal Proteins
1
2005
156
0.010
 Why?
Biological Evolution
1
1989
464
0.010
 Why?
Intellectual Disability
1
2006
163
0.010
 Why?
Interferon Type I
1
1985
141
0.010
 Why?
Cytoskeleton
1
2005
186
0.010
 Why?
Kinetics
2
1998
1668
0.010
 Why?
United States
1
2021
14660
0.010
 Why?
Fever
1
2005
307
0.010
 Why?
Bronchitis
1
2003
44
0.010
 Why?
Actins
1
2005
415
0.010
 Why?
Chemokine CCL22
1
2002
3
0.010
 Why?
Apoptosis
1
2012
2548
0.010
 Why?
Hearing Loss
1
2006
220
0.010
 Why?
Echocardiography
1
2005
659
0.010
 Why?
Interphase
1
2001
32
0.010
 Why?
Gene Expression Regulation, Neoplastic
1
2008
1396
0.010
 Why?
HL-60 Cells
1
2001
33
0.010
 Why?
Sodium Dodecyl Sulfate
1
2001
26
0.010
 Why?
Palatine Tonsil
1
2001
48
0.010
 Why?
K562 Cells
1
2001
89
0.010
 Why?
Sinusitis
1
2003
221
0.010
 Why?
Receptors, Antigen, B-Cell
1
2001
130
0.010
 Why?
Immunoglobulin M
1
2001
288
0.010
 Why?
Protein Isoforms
1
2001
400
0.010
 Why?
Oxazolone
1
1999
5
0.010
 Why?
Immunomagnetic Separation
1
1999
5
0.010
 Why?
Ear, External
1
1999
22
0.010
 Why?
Blood Cells
1
1999
40
0.010
 Why?
Muscle, Skeletal
1
2009
1707
0.010
 Why?
RNA, Messenger
1
1987
2831
0.010
 Why?
Carbohydrate Metabolism
1
1998
61
0.010
 Why?
Endothelium
1
1999
122
0.010
 Why?
Carbohydrates
1
1998
66
0.010
 Why?
Diffusion Chambers, Culture
1
1997
9
0.010
 Why?
Chemotactic Factors, Eosinophil
1
1997
7
0.010
 Why?
Integrin alpha4
1
1997
7
0.010
 Why?
Chemokine CCL11
1
1997
26
0.010
 Why?
Aged, 80 and over
1
2010
7569
0.010
 Why?
Antigens, Surface
1
1998
153
0.010
 Why?
Protein Conformation
1
2000
940
0.010
 Why?
Peptide Fragments
1
2001
707
0.010
 Why?
Chymotrypsin
1
1996
22
0.010
 Why?
In Vitro Techniques
1
1998
1089
0.010
 Why?
Time Factors
1
1987
6792
0.010
 Why?
Chemokine CCL2
1
1996
115
0.010
 Why?
Carbohydrate Sequence
1
1995
27
0.010
 Why?
Mutation
1
2006
3953
0.010
 Why?
Chromatography, High Pressure Liquid
1
1996
591
0.010
 Why?
Prognosis
1
2002
4018
0.010
 Why?
Phylogeny
1
1996
896
0.010
 Why?
Cell Fractionation
1
1989
56
0.000
 Why?
Lymphokines
1
1989
131
0.000
 Why?
Nucleic Acid Hybridization
1
1989
190
0.000
 Why?
Mice, Inbred C3H
1
1989
269
0.000
 Why?
Culture Media
1
1989
167
0.000
 Why?
T-Lymphocytes, Helper-Inducer
1
1989
137
0.000
 Why?
Drug Combinations
1
1989
344
0.000
 Why?
Hybrid Cells
1
1987
49
0.000
 Why?
Spleen
1
1989
513
0.000
 Why?
Polymorphism, Restriction Fragment Length
1
1987
68
0.000
 Why?
Genetic Markers
1
1987
344
0.000
 Why?
Recombination, Genetic
1
1987
198
0.000
 Why?
Chromosome Mapping
1
1987
523
0.000
 Why?
Cytotoxicity, Immunologic
1
1985
225
0.000
 Why?
Peptides
1
1987
980
0.000
 Why?
Immunotherapy
1
1985
640
0.000
 Why?
Fuhlbrigge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (504) concept(s)
_
Co-Authors Expand Description
See all (27) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)